Ergoteles LLC - ONCOCYTE CORP ownership

Back to all holdings Add to watchlist

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 90 filers reported holding ONCOCYTE CORP in Q4 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Ergoteles LLC ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q4 2022$32,974
-29.8%
102,756
+59.8%
0.00%
-50.0%
Q3 2022$47,000
-77.5%
64,302
-72.3%
0.00%
-66.7%
Q2 2022$209,000
+38.4%
232,133
+448.8%
0.01%0.0%
Q3 2021$151,000
+33.6%
42,300
+114.7%
0.01%
+100.0%
Q2 2021$113,000–19,700–0.00%–
 Download
Other shareholders
ONCOCYTE CORP shareholders Q4 2021
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 1,093,219$6,833,0001.15%
HUNTINGTON NATIONAL BANK 10$00.00%
CITIGROUP INC 642$4,0000.00%
Sonora Investment Management, LLC 50$00.00%
BARCLAYS PLC 206$1,0000.00%
BLACKROCK ADVISORS LLC 96$1,0000.00%
View complete list of ONCOCYTE CORP shareholders